Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Experimental and clinical data analysis for identification of COVID-19 resistant ACE2 mutations.

Scientific reports - 9 Feb 2023

Raghav Pawan Kumar, Raghav Aditya, Lathwal Anjali, Saxena Archit, Mann Zoya, Sengar Manisha, Rajalingam Raja

Abstract excerpt

The high magnitude zoonotic event has caused by Severe Acute Respitarory Syndrome CoronaVirus-2 (SARS-CoV-2) is Coronavirus Disease-2019 (COVID-19) epidemics. This disease has high rate of spreading than mortality in humans. The human receptor, Angiotensin-Converting Enzyme 2 (ACE2), is the leading target site for viral Spike-protein (S-protein) that function as binding ligands and are responsible for their entry...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiotensin-Converting Enzyme 2
Share to Carrier Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to COVID-19

Share to Mutation

Share to Peptidyl-Dipeptidase A

Share to Protein Binding

Share to SARS-CoV-2

Share to SARS-CoV-2 and COVID-19 Research

Source

Open in PubMed Open full text

Identifiers

PMID: 36759535
DOI: 10.1038/s41598-022-20773-9
PMCID: PMC9910265

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Experimental and clinical data analysis for identification of COVID-19 resistant ACE2 mutations.PMID 36759535Read ↗

Potential COVID‐19 therapeutic approaches targeting angiotensin‐converting enzyme 2; An updated reviewSemantic proximity Read ↗

Variants in ACE2; potential influences on virus infection and COVID-19 severity.Semantic proximity Read ↗

Role of SARS-CoV-2 and ACE2 variations in COVID-19.Semantic proximity Read ↗

Susceptibilities of human ACE2 genetic variants in coronavirus infectionSemantic proximity Read ↗

Contributions of human ACE2 and TMPRSS2 in determining host-pathogen interaction of COVID-19.Semantic proximity Read ↗

Human ACE2 receptor polymorphisms predict SARS-CoV-2 susceptibilitySemantic proximity Read ↗

Investigating the ACE2 polymorphisms in COVID-19 susceptibility: An in silico analysis.Semantic proximity Read ↗

Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2.Semantic proximity Read ↗

A Closer Look at ACE2 Signaling Pathway and Processing during COVID-19 Infection: Identifying Possible TargetsSemantic proximity Read ↗

Angiotensin-converting enzyme 2—at the heart of the COVID-19 pandemicSemantic proximity Read ↗

The Impact of ACE2 Polymorphisms on COVID-19 Disease: Susceptibility, Severity, and TherapySemantic proximity Read ↗

Structural variations in human ACE2 may influence its binding with SARS-CoV-2 spike protein.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.